Merck & Co Inc
MRKNYSEPharmaceuticals
$145.19
Down−$2.18 (−1.48%)today
Market closed · refreshes every 30sLast trade Oct 15, 4:00 PM EDT
Key stats
- Open
- $149.70
- Previous close
- $147.37
- Day range
- $144.91 – $152.34
- 52-week range
- $82.01 – $156.92
- Market cap
- $358.21B
- P/E ratio
- 116.64
- Dividend yield
- 2.87%
- Beta
- 0.12
News about MRK
- YahooAI Stocks Are Hurting. Look at These Other Sectors for Protection.
Investors are fleeing tech stocks due to artificial-intelligence worries. But many other sectors of the market look like a good bet.
- YahooHow Has Merck's Story Changed?
Investors are pricing Merck (MRK) stock at 5.5 times sales, compared with 3.1 for the S&P 500. Shareholders paying that premium need to understand exactly what they hold, and the drugmaker's priorities have changed. During the fiscal Q4 2024 call in February 2025, executives noted that conditions for the GARDASIL vaccine in China remained challenging. By the August 4, 2026 call, management emphasized something else. So what does management talk up now.
- YahooAs chip stocks fall, investors are turning elsewhere in the market: Chart of the Day
Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look at the latest market and sector action, highlighting what the sell-off in CoreWeave (CRWV) and chip stocks means for the rest of the market.
- YahooWhat Could Merck (MRK) Reveal At ESMO 2026 About Its Oncology Pipeline?
Your position
Sign in to track your MRK shares and return.
Add to portfolioAbout
- Exchange
- NYSE
- Industry
- Pharmaceuticals
- Listed
- 1941-01-01